(Q40093906)

English

The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity

scientific article published on August 2007

Statements

The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity (English)
Sheila Miknyoczki
Hong Chang
Jennifer Grobelny
Sonya Pritchard
Candace Worrell
Natalie McGann
Mark Ator
Jean Husten
James Deibold
Robert Hudkins
Allison Zulli
Ralph Parchment
Bruce Ruggeri
1 August 2007
2290-2302

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit